DisclosureWe earn commission on partner links; ranking is set by clinician-vetted methodology — not advertisers.
Health services company with ~17M US medical members + Evernorth PBM
Cigna operates US commercial health plans plus the Evernorth PBM. Among the more restrictive commercial plans for weight-loss GLP-1s — many Cigna employer groups exclude weight-loss drugs entirely as a cost-control measure.
Cigna coverage of weight-loss GLP-1s varies dramatically by employer group — many large employers exclude weight-loss drugs entirely. Diabetes coverage is standard at tier 2-3. Express Scripts (Evernorth) PBM applies step therapy requiring metformin trial before tirzepatide.
Sample copays based on a representative Cigna plan. Your specific plan may differ.
| Product | Status | Sample copay |
|---|---|---|
| Hims & Hers Weight Loss | Not covered | — |
| Mounjaro T2D + metformin + GLP-1 monotherapy trial | Step therapy | $45/mo |
| Ozempic T2D + metformin trial (3+ months at max dose) | Step therapy | $45/mo |
| Zepbound Same as Wegovy — employer-dependent | Varies | $80/mo |
| Wegovy Employer-dependent. Most large employers exclude weight-loss entirely. | Varies | $80/mo |
Look up your specific plan ID for plan-level accuracy. Open formulary tool
Coverage shown is a sample plan and not a guarantee for your specific Cigna plan. Always verify with member services or your benefits administrator. We update this page when formulary changes are detected — last verified May 16, 2026.
Looking for a specific medication? Browse all GLP-1 reviews →